Literature DB >> 21442928

[Chitosan antiviral activity: dependence on structure and depolymerization method].

V N Davydova, V P Nagorskaia, V I Gorbach, A A Kalitnik, A V Reunov, T F Solov'eva, I M Ermak.   

Abstract

Enzymatic (the action of lysozyme) and chemical (hydrogen peroxide) hydrolysis of chitosans with various degree ofacetylation (DA)--25, 17, and 1.5%--was performed. Purification and fractioning of the hydrolysis products were performed using dialysis, ultrafiltration, and gel-penetrating chromatography Low-molecular (LM) derivatives of the polysaccharide with molecular masses from 17 to 2 kDa were obtained. The study of their antiviral activity against the tobacco mosaic virus (TMV) showed that these samples inhibited the formation of local necroses induced by the virus for 50-90%. The antiviral activity of the LM chitosans significantly increased with the lowering of their polymerization degree. Furthermore, the products of the enzymatic hydrolysis possessed higher activity than the chitosan samples obtained as a result of chemical hydrolysis. It was revealed that the exhibition of the antiviral activity weakly depended on the degree of acetylation of the samples.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442928

Source DB:  PubMed          Journal:  Prikl Biokhim Mikrobiol        ISSN: 0555-1099


  9 in total

1.  Chitosan-induced antiviral activity and innate immunity in plants.

Authors:  Marcello Iriti; Elena Maria Varoni
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-17       Impact factor: 4.223

Review 2.  The antiviral activities and mechanisms of marine polysaccharides: an overview.

Authors:  Wei Wang; Shi-Xin Wang; Hua-Shi Guan
Journal:  Mar Drugs       Date:  2012-12-12       Impact factor: 5.118

3.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

Review 4.  Enzymatic Modifications of Chitin, Chitosan, and Chitooligosaccharides.

Authors:  Michal Benedykt Kaczmarek; Katarzyna Struszczyk-Swita; Xingkang Li; Miroslawa Szczęsna-Antczak; Maurycy Daroch
Journal:  Front Bioeng Biotechnol       Date:  2019-09-27

5.  Biological activity of chitosan inducing resistance efficiency of rice (Oryza sativa L.) after treatment with fungal based chitosan.

Authors:  Vethamonickam Stanley-Raja; Sengottayan Senthil-Nathan; Kanagaraj Muthu-Pandian Chanthini; Haridoss Sivanesh; Ramakrishnan Ramasubramanian; Sengodan Karthi; Narayanan Shyam-Sundar; Prabhakaran Vasantha-Srinivasan; Kandaswamy Kalaivani
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

Review 6.  Polysaccharides and Their Derivatives as Potential Antiviral Molecules.

Authors:  Hadrien Claus-Desbonnet; Elsa Nikly; Vanya Nalbantova; Diana Karcheva-Bahchevanska; Stanislava Ivanova; Guillaume Pierre; Niko Benbassat; Plamen Katsarov; Philippe Michaud; Paolina Lukova; Cédric Delattre
Journal:  Viruses       Date:  2022-02-18       Impact factor: 5.048

Review 7.  Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine.

Authors:  Rebecca Shu Ling Tan; Pouya Hassandarvish; Chin Fei Chee; Lai Wah Chan; Tin Wui Wong
Journal:  Carbohydr Polym       Date:  2022-04-20       Impact factor: 10.723

8.  First Insights into the Antiviral Activity of Chitosan-Based Bioactive Polymers towards the Bacteriophage Phi6: Physicochemical Characterization, Inactivation Potential, and Inhibitory Mechanisms.

Authors:  Olivija Plohl; Katja Fric; Arijana Filipić; Polona Kogovšek; Magda Tušek Žnidarič; Lidija Fras Zemljič
Journal:  Polymers (Basel)       Date:  2022-08-17       Impact factor: 4.967

Review 9.  A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19.

Authors:  Nisrein Jaber; Mayyas Al-Remawi; Faisal Al-Akayleh; Najah Al-Muhtaseb; Ibrahim S I Al-Adham; Phillip J Collier
Journal:  J Appl Microbiol       Date:  2021-07-26       Impact factor: 4.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.